Online Voice quality education module for Hoarseness

Phase-Based Progress Estimates
HoarsenessOnline Voice quality education module - Other
18 - 100
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether adding educational online modules to voice therapy can help improve outcomes by increasing patient engagement and understanding.

Treatment Effectiveness

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Baseline (Day 1) visit, 8 - 10 week visit

Week 10
Change of patient's perception on voice therapy
Change of perceived effectiveness of voice therapy
Change of perceptual voice ratings
Change of voice handicap perception across the 3 groups
Month 4
Change of Online education module acceptance across the 3 groups

Trial Safety

Trial Design

3 Treatment Groups

Control group
1 of 3
Experimental Group
1 of 3
Sham Control Group
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

120 Total Participants · 3 Treatment Groups

Primary Treatment: Online Voice quality education module · Has Placebo Group · N/A

Experimental Group
Experimental Group · 1 Intervention: Online Voice quality education module · Intervention Types: Other
Sham Control Group
ShamComparator Group · 1 Intervention: Vocal hygiene module · Intervention Types: Other
Control groupNoIntervention Group · 1 Intervention: Control group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline (day 1) visit, 8 - 10 week visit

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,264 Previous Clinical Trials
753,471 Total Patients Enrolled
1 Trials studying Hoarseness
8 Patients Enrolled for Hoarseness
Aaron Johnson, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
18 Total Patients Enrolled

Eligibility Criteria

Age 18 - 100 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have the ability to give informed consent.
You are willing to complete all clinical/research assessments.